Manufacturer record
Super formulations Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
16 batches manufactured by Super formulations Pvt. Ltd (Madhya Pradesh) were declared Not of Standard Quality between July 2021 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
16 records linked to Super formulations Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Oral Rehydration Salts IP | 4063Mfg 2026-05 · Exp 2028-04 | Net WeightWeight | Govt Analyst PunjabState lab | Jul 2026 |
| Oral Rehydration Salts IP | 4057Mfg 2026-05 · Exp 2028-04 | Net WeightWeight | Govt Analyst PunjabState lab | Jul 2026 |
| Telmisartan Tablets IP 40mg | GTM94Mfg 2025-05 · Exp 2027-04 | DissolutionDissolution | DTL, Chennai-06State lab | Jun 2026 |
| Oral Rehydration Salts IP | 4047Mfg 2026-03 · Exp 2028-02 | Net WeightWeight | SDTL, PunjabState lab | Jun 2026 |
| Oral Rehydration Salts IP | 4043Mfg 2026-03 · Exp 2028-02 | Net WeightWeight | SDTL, PunjabState lab | Jun 2026 |
| ORAL REHYDRATION SALTS IP | 4033Mfg 2026-03 · Exp 2028-03 | Average Net Contents per sachet found to be 20.3532gm against claim of 20.5gm per sachetOther | SDTL, PunjabState lab | Jun 2026 |
| Amitriptyline Tablets IP 25 mg | GAMT4Mfg 2025-10 · Exp 2027-09 | ContentOther | DTL, Madurai-19State lab | Jun 2026 |
| Amlodipine Tablets IP 5mg | GAB36Mfg 2025-11 · Exp 2027-10 | The sample received does not conform to I.P. 2022 with respect to the test for Related substances other test could not be done due to technical reason.Related substances | CDTL, MumbaiCDSCO lab | May 2026 |
| Vitamin B-Complex Tablets NFI (Prophylactic) | GBC239Mfg 2025-06 · Exp 2026-11 | ContentOther | DTL,ChennaiState lab | Mar 2026 |
| Telmisartan Tablets IP 40mg | GTM52Mfg 2025-02 · Exp 2027-01 | DissolutionDissolution | DTL,ChennaiState lab | Mar 2026 |
| Telmisartan Tablets IP 40mg | GTM54Mfg 2025-02 · Exp 2027-01 | Dissolution.Dissolution | DTL, Chennai-06State lab | Feb 2026 |
| Amitriptyline Tablets IP 25mg | GAMT2Mfg 2025-06 · Exp 2027-05 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Nov 2025 |
| Amitriptyline Tablets IP 25 mg | GAMT1Mfg 2025-05 · Exp 2027-04 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Nov 2025 |
| Carbamazepine Tablets IP 200 mg | GCB5Mfg 2022-12 · Exp 2024-11 | DISSOLUTIONDissolution | CDTL ChennaiCDSCO lab | Jul 2023 |
| Doxycycline Hydrochloride Capsules I.P. 100 mg | 2002Mfg 2021-05 · Exp 2023-04 | AssayAssay | CDL KolkataCDSCO lab | Mar 2022 |
| Doxycycline Hydrochloride Capsules I.P. 100 mg | 3157Mfg 2020-03 · Exp 2022-02 | AssayAssay | CDL KolkataCDSCO lab | Jul 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.